Navigation Links
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
Date:5/4/2009

Alliance Aims to First Develop Powerful Tools for Detecting Ovarian Cancer Earlier

FRANKLIN LAKES, N.J. and MALVERN, Pa., May 4 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) and Fujirebio Diagnostics, Inc., announced today the signing of a worldwide development and supply agreement for oncology diagnostic assays.

Under the agreement, the two companies will develop diagnostic products that incorporate Fujirebio Diagnostics' cancer biomarkers for use on BD's multiplex testing platform. The initial products will be directed to the ovarian cancer biomarker, HE4, which is FDA-cleared for monitoring the progression or recurrence of epithelial ovarian cancer. Fujirebio Diagnostics also grants BD, through its BD Diagnostics - TriPath platform, access to its other cancer biomarkers for inclusion in future multiplex diagnostic products.

"BD is investing in the development of tools and technologies essential for biomarker-guided cancer care. We believe that biomarker testing in a multiplex format can provide clinicians with a powerful toolset for detecting cancer at an earlier stage, which could allow them to begin treatment sooner and improve outcomes," said Wayne Brinster, Vice President and General Manager for Women's Health and Cancer, BD. "By incorporating Fujirebio Diagnostics' cancer biomarkers within our own cancer diagnostics development program, we believe that we are poised to provide clinicians with innovative diagnostic tools for improved patient management and contribute to BD's growth in cancer diagnostics."

"This alliance with BD is an excellent strategic fit for Fujirebio Diagnostics' business," said Paul Touhey, President and Chief Executive Officer, Fujirebio Diagnostics. "It will increase the use of HE4 as a tool in monitoring ovarian cancer and allow Fuji
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Fujirebio Diagnostics Named One of the Best Places to Work in Pennsylvania
2. Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006
3. New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague
4. Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
5. Allegro Diagnostics Expands Board and Executive Team
6. Frost & Sullivan: In Vitro Diagnostics Market
7. Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board
8. Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation
9. Innovative Biosensors and ProGenTech Partner to Develop a Rapid Diagnostics System
10. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
11. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... D.C (PRWEB) September 22, 2014 FierceBiotech ... top privately held biotechnology companies of 2014. FierceBiotech ... companies before selecting this year’s winners. Those selected ... biotechnology companies in the industry. , "It's ... new group of Fierce 15 companies," said Carroll. "This ...
(Date:9/22/2014)... 2014  Spherix Incorporated (SPEX) -- an intellectual property development ... today announced that the United States Patent & Trademark Office ... month of September that is part of a standard essential ... USRE45,121 , Application number: US 13/728,867 , ... 27, 2012 The listed inventors of the ...
(Date:9/20/2014)... 20, 2014 HealthTronics, Inc. ... interventional radiology products and services, has signed a ... Clinicon Corporation for its high precision ... of minimally invasive, mobile, surgical technology—offering more choices ... the agreement, HealthTronics will make available Clinicon’s FDA-cleared ...
(Date:9/19/2014)... that use light, rather than electricity, to move ... energy efficiency is a growing concern as chips, ... components of optical circuits light emitters, modulators, ... build. One promising light source for optical chips ... properties when deposited as a single, atom-thick layer. ...
Breaking Biology Technology:FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Toward optical chips 2Toward optical chips 3
... July 1 Pharmasset, Inc.,(Nasdaq: VRUS ) joined ... equity indexes on June 27., Pharmasset,s membership in ... means automatic inclusion in the small-cap Russell 2000(R) Index,as ... Russell indexes,are widely used by investment managers for index ...
... Inc. ("ChromaDex"),today announced that effective June 20, 2008, ... the wholly-owned subsidiary of Cody,Resources, Inc. ("Cody") (OTC ... wholly owned by a company whose shares are ... to meet the ongoing needs,of a rapidly growing ...
... and Ben Eynon Each Assume Vice President Roles at ... ... the,market and technology leader of nanopatterning systems and solutions, today,announced that ... industry veterans are assuming the roles of vice,president of marketing and ...
Cached Biology Technology:Pharmasset Joins Russell 3000 Index 2ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc. 2Industry Veterans Join Molecular Imprints' Management Team 2Industry Veterans Join Molecular Imprints' Management Team 3
(Date:9/22/2014)... SHELTON, Conn. , Sept. 22, 2014 ... authentication company focused on the growing mobile commerce market, ... to NASDAQ and the recent funding. ... recently completed an essential round of funding and joined ... as well as expand its other biometric and authentication ...
(Date:9/21/2014)... 22, 2014The story of cowpea (black-eyed peas) is a ... biggest problemseven more fascinating is the story of the ... Cowpea: The Food Legume of the 21st Century to ... and use. The book was recently published by the ... Institute of Tropical Agriculture (IITA). , Singh has devoted ...
(Date:9/21/2014)... previously thought, newborn immune T cells may have the ... to a new study led by King,s College London. ... of adults, babies may still be able to mount ... the journal Nature Medicine . , Our immune ... immune cells, including neutrophils which play an important role ...
Breaking Biology News(10 mins):NXT-ID Issues Shareholder Corporate Update 2NXT-ID Issues Shareholder Corporate Update 3NXT-ID Issues Shareholder Corporate Update 4Immune system of newborn babies is stronger than previously thought 2
... Sower, professor of biochemistry and director of the Center ... New Hampshire, has received a $420,000 grant from the ... pituitary hormones and receptors. With the four-year ... research in the fields of hormonal genomics and proteomics. ...
... New software developed with help from the Wildlife ... individual animals by creating a three-dimensional model using photos ... an issue of the journal Biology Letters , ... confiscated skins. The new software, developed by Conservation Research ...
... 12, 2009) Researchers from DaVinci Biosciences, Costa Mesa, ... have determined that injecting a patient,s own bone marrow-derived ... using multiple routes can be an effective treatment for ... life for SCI patients without serious adverse events. Publishing ...
Cached Biology News:Major NSF grant boosts UNH research on hormonal genomics 2Tracking tigers in 3-D 2Multiple route bone marrow stem cell injections show promise to treat spinal cord injury 2
Agar, 5 lb. Bacteriological.Moisture: < 10%, ash: < 6.5%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Agar, 500 g. Noble Agar.Moisture: < 10%, ash: < 1.6%, EEO (-mr): < 0.450 (pH 8.4). Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
... Immunogen: Synthetic peptide derived from an ... mTOR (Mammalian target of rapamycin FRAP RAFT1 ... mTOR protein. On Western blots it ... Reactivity: Human (positive control: HEK293 cell ...
Biology Products: